Given the heterogenous nature of ovarian cancer tissues and the fact that YKL40 is a secreted factor, comprehensive evaluations using plasma or mRNA derived from whole tissues rather than immunohistochemical evaluation using limited tissue samples may provide more accurate assessments. The gene discussed is CHI3L1; the disease is ovarian cancer.